Heba Z. Khella
Toronto, ON M2H3J1, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications
Molecular docking and experimental validation for the protective effect of betanin against capecitabine-induced myocardial injury: Binding to TLR4 and downregulation of MyD88/NFκB signaling.
Journal: Tissue & cell
Published: September 29, 2025
Leflunomide-induced cardiac injury in adult male mice and bioinformatic approach identifying Nrf2/NF-κb signaling interplay.
Journal: Toxicology mechanisms and methods
Published: February 23, 2024
Betanin improves motor function and alleviates experimental Parkinsonism via downregulation of TLR4/MyD88/NF-κB pathway: Molecular docking and biological investigations.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: March 30, 2023
Clinical Biomarker of Sterile Inflammation, HMGB1, in Patients with Chronic Non-Specific Low Back Pain: A Pilot Cross-Sectional Study.
Journal: Life (Basel, Switzerland)
Published: December 22, 2022
Translational research: Empowering the role of pathologists and cytopathologists.
Journal: Cancer cytopathology
Published: May 21, 2018
Therapeutic Targeting of TFE3/IRS-1/PI3K/mTOR Axis in Translocation Renal Cell Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 30, 2018
miR-10b is a prognostic marker in clear cell renal cell carcinoma.
Journal: Journal of clinical pathology
Published: January 12, 2017
Exosomal MicroRNAs Are Diagnostic Biomarkers and Can Mediate Cell-Cell Communication in Renal Cell Carcinoma.
Journal: European urology focus
Published: September 11, 2015
MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma.
Journal: Cancer medicine
Published: August 20, 2015
miR-221/222 Are Involved in Response to Sunitinib Treatment in Metastatic Renal Cell Carcinoma.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 08, 2015
miRNA-target network reveals miR-124as a key miRNA contributing to clear cell renal cell carcinoma aggressive behaviour by targeting CAV1 and FLOT1.
Journal: Oncotarget
Published: February 18, 2015
Last Updated: 09/26/2026